AGREEMENT AND PLAN OF MERGER BY AND AMONG INTERPRIVATE III FINANCIAL PARTNERS INC., INTERPRIVATE III MERGER SUB INC., INTERPRIVATE III MERGER SUB II LLC AND ASPIRATION PARTNERS INC. DATED AS OF AUGUST 18, 2021Merger Agreement • August 19th, 2021 • InterPrivate III Financial Partners Inc. • Blank checks • Delaware
Contract Type FiledAugust 19th, 2021 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER is made and entered into as of August 18, 2021, by and among InterPrivate III Financial Partners Inc., a Delaware corporation (“Parent”), InterPrivate III Merger Sub Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent (“Merger Sub”), InterPrivate III Merger Sub II LLC, a Delaware limited liability company and a direct, wholly-owned subsidiary of Parent (“Merger Sub II”), and Aspiration Partners Inc., a Delaware corporation (the “Company”). Each of the Company, Parent, Merger Sub and Merger Sub II shall individually be referred to herein as a “Party” and, collectively, the “Parties”. The term “Agreement” as used herein refers to this Agreement and Plan of Merger, as the same may be amended from time to time, and all schedules, exhibits and annexes hereto (including the Company Disclosure Letter and the Parent Disclosure Letter, as defined herein). Defined terms used in this Agreement are listed alphabetically in Schedule A, toge
AGREEMENT AND PLAN OF MERGER BY AND AMONG CM LIFE SCIENCES III INC., CLOVER III MERGER SUB INC., and eqrx, inc. DATED AS OF August 5, 2021Merger Agreement • August 6th, 2021 • CM Life Sciences III Inc. • Blank checks • Delaware
Contract Type FiledAugust 6th, 2021 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER is made and entered into as of August 5, 2021, by and among CM Life Sciences III Inc., a Delaware corporation (“Parent”), Clover III Merger Sub Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent (“Merger Sub”), and EQRx, Inc., a Delaware corporation (the “Company”). Each of the Company, Parent and Merger Sub shall individually be referred to herein as a “Party” and, collectively, the “Parties”. The term “Agreement” as used herein refers to this Agreement and Plan of Merger, as the same may be amended from time to time, and all schedules, exhibits and annexes hereto (including the Company Disclosure Letter and the Parent Disclosure Letter, as defined herein). Defined terms used in this Agreement are listed alphabetically in Schedule A, together with the section and, if applicable, subsection in which the definition of each such term is located.
AGREEMENT AND PLAN OF MERGER BY AND AMONG CM LIFE SCIENCES II, INC., S-CRAFT MERGER SUB, INC., and SomaLogic, Inc., DATED AS OF MARCH 28, 2021Merger Agreement • March 29th, 2021 • CM Life Sciences II Inc. • Blank checks • Delaware
Contract Type FiledMarch 29th, 2021 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER is made and entered into as of March 28, 2021, by and among CM Life Sciences II, Inc., a Delaware corporation (“Parent”), S-Craft Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent (“Merger Sub”), and SomaLogic, Inc., a Delaware corporation (the “Company”). Each of the Company, Parent and Merger Sub shall individually be referred to herein as a “Party” and, collectively, the “Parties”. The term “Agreement” as used herein refers to this Agreement and Plan of Merger, as the same may be amended from time to time, and all schedules, exhibits and annexes hereto (including the Company Disclosure Letter and the Parent Disclosure Letter, as defined herein). Defined terms used in this Agreement are listed alphabetically in Schedule A, together with the section and, if applicable, subsection in which the definition of each such term is located.
AGREEMENT AND PLAN OF MERGER BY AND AMONG CM LIFE SCIENCES, INC., S-IV SUB, INC., and MOUNT SINAI GENOMICS, INC., DATED AS OF FEBRUARY 9, 2021Merger Agreement • February 11th, 2021 • CM Life Sciences, Inc. • Blank checks • Delaware
Contract Type FiledFebruary 11th, 2021 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER is made and entered into as of February 9, 2021, by and among CM Life Sciences, Inc., a Delaware corporation (“Parent”), S-IV Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent (“Merger Sub”), and Mount Sinai Genomics, Inc., a Delaware corporation, d/b/a Sema4 (the “Company”). Each of the Company, Parent and Merger Sub shall individually be referred to herein as a “Party” and, collectively, the “Parties”. The term “Agreement” as used herein refers to this Agreement and Plan of Merger, as the same may be amended from time to time, and all schedules, exhibits and annexes hereto (including the Company Disclosure Letter and the Parent Disclosure Letter, as defined herein). Defined terms used in this Agreement are listed alphabetically in Schedule A, together with the section and, if applicable, subsection in which the definition of each such term is located.
AGREEMENT AND PLAN OF MERGER BY AND AMONG LF CAPITAL ACQUISITION CORP., LFCA MERGER SUB, INC., LANDSEA HOMES INCORPORATED and LANDSEA HOLDINGS CORPORATION DATED AS OF AUGUST 31, 2020Merger Agreement • August 31st, 2020 • LF Capital Acquisition Corp. • Blank checks • Delaware
Contract Type FiledAugust 31st, 2020 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER is made and entered into as of August 31, 2020, by and among LF Capital Acquisition Corp., a Delaware corporation (“Parent”), LFCA Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent (“Merger Sub”), and Landsea Homes Incorporated, a Delaware corporation (the “Company”), and Landsea Holdings Corporation, a Delaware corporation (the “Seller”). Each of the Company, Parent, Merger Sub and the Seller shall individually be referred to herein as a “Party” and, collectively, the “Parties”. The term “Agreement” as used herein refers to this Agreement and Plan of Merger, as the same may be amended from time to time, and all schedules, exhibits and annexes hereto (including the Disclosure Schedules, as defined herein). Defined terms used in this Agreement are listed alphabetically in Schedule A, together with the section and, if applicable, subsection in which the definition of each such term is located.